<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Dominantly acting mutations of the fibroblast growth factor (FGF) receptor 2 (FGFR2) gene have been implicated in various <z:hpo ids='HP_0001363'>craniosynostosis</z:hpo> syndromes </plain></SENT>
<SENT sid="1" pm="."><plain><z:e sem="disease" ids="C0001193" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Apert syndrome</z:e>, characterized in addition by <z:hpo ids='HP_0001159'>syndactyly</z:hpo> of the limbs, involves specific mutations at two adjacent residues, Ser252Trp and Pro253Arg, predicted to lie in the linker region between IgII and IgIII of the FGFR2 ligand-binding domain </plain></SENT>
<SENT sid="2" pm="."><plain>We have analysed the interaction of FGF ligands with <z:mp ids='MP_0002169'>wild-type</z:mp> and <z:e sem="disease" ids="C0001193" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Apert</z:e>-type mutant FGFR2 ectodomains in solution </plain></SENT>
<SENT sid="3" pm="."><plain><z:mp ids='MP_0002169'>Wild-type</z:mp> and <z:e sem="disease" ids="C0001193" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Apert</z:e>-type receptors form a complex with FGF ligands with a stoichiometry of 2:2 (ligand:receptor) </plain></SENT>
<SENT sid="4" pm="."><plain>The kinetics and specificity of ligand binding to <z:mp ids='MP_0002169'>wild-type</z:mp> and <z:e sem="disease" ids="C0001193" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Apert</z:e> mutant receptors have been analysed using surface plasmon resonance techniques </plain></SENT>
<SENT sid="5" pm="."><plain>This reveals that <z:e sem="disease" ids="C0001193" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Apert</z:e> mutations, compared with <z:mp ids='MP_0002169'>wild-type</z:mp>, exhibit a selective decrease in the dissociation kinetics of FGF2, but not of other FGF ligands examined </plain></SENT>
<SENT sid="6" pm="."><plain>In contrast, the substitution Ser252Leu in FGFR2, previously observed in several asymptomatic individuals, exhibited <z:mp ids='MP_0002169'>wild-type</z:mp> kinetics </plain></SENT>
<SENT sid="7" pm="."><plain>These findings indicate that <z:e sem="disease" ids="C0001193" disease_type="Disease or Syndrome;Congenital Abnormality" abbrv="">Apert syndrome</z:e> arises as a result of increased affinity of mutant receptors for specific FGF ligands which leads to activation of signalling under conditions where availability of ligand is limiting </plain></SENT>
</text></document>